We are live on ! Find out more
NCM

Novare Capital Management Portfolio holdings

AUM $1.41B
1-Year Est. Return 25.38%
This Fund
S&P 500
This Quarter Est. Return
+1.51%
1 Year Est. Return
+25.38%
3 Year Est. Return
+76.47%
5 Year Est. Return
+92.66%
10 Year Est. Return
+281.33%
AUM
$402M
AUM Growth
-$6.58M
Cap. Flow
-$3.14M
Cap. Flow %
-0.78%
Top 10 Hldgs %
25.32%
Holding
127
New
5
Increased
49
Reduced
44
Closed
12

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$5.04M
2
NSC icon
Norfolk Southern
NSC
+$4.97M
3
SLB icon
SLB Ltd
SLB
+$4.06M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$2.92M
5
WMB icon
Williams Companies
WMB
+$1.02M

Sector Composition

Rank Sector Weight
1 Energy 24.44%
2 Healthcare 12.38%
3 Financials 12.15%
4 Industrials 8.72%
5 Consumer Discretionary 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ET icon
26
Energy Transfer Partners
ET
$69.3B
$5.91M 1.47%
206,106
IJH icon
27
iShares Core S&P Mid-Cap ETF
IJH
$127B
$5.87M 1.46%
202,685
+1,885
+0.9% +$53K
WP
28
DELISTED
Worldpay, Inc.
WP
$5.83M 1.45%
171,820
+6,700
+4% +$217K
COV
29
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$5.69M 1.41%
55,611
-1,522
-3% -$146K
JNJ icon
30
Johnson & Johnson
JNJ
$625B
$5.67M 1.41%
54,233
+1,326
+3% +$140K
EBAY icon
31
eBay
EBAY
$49.7B
$5.5M 1.37%
233,007
-9,088
-4% -$206K
DIS icon
32
Walt Disney
DIS
$181B
$5.47M 1.36%
58,032
+645
+1% +$58.2K
PFE icon
33
Pfizer
PFE
$153B
$5.45M 1.36%
184,474
+175,870
+2,044% +$5.04M
FITB
34
Fifth Third Bancorp
FITB
$51.8B
$5.07M 1.26%
248,782
+7,022
+3% +$139K
AXP icon
35
American Express
AXP
$230B
$5.01M 1.25%
53,887
+2,110
+4% +$189K
NSC icon
36
Norfolk Southern
NSC
$75.1B
$4.97M 1.23%
+45,305
New +$4.97M
RF icon
37
Regions Financial
RF
$26.8B
$4.82M 1.2%
456,565
+3,665
+0.8% +$36.6K
AZO icon
38
AutoZone
AZO
$51.1B
$4.71M 1.17%
7,612
-36
-0.5% -$20.3K
ASH icon
39
Ashland
ASH
$3.5B
$4.64M 1.15%
79,174
+1,829
+2% +$98.6K
LKQ icon
40
LKQ Corp
LKQ
$6.29B
$4.55M 1.13%
161,723
+3,575
+2% +$99.8K
MDRX
41
DELISTED
Veradigm Inc. Common Stock
MDRX
$4.39M 1.09%
343,815
+15,610
+5% +$199K
BPL
42
DELISTED
Buckeye Partners, L.P.
BPL
$4.34M 1.08%
57,368
+175
+0.3% +$13.5K
SLB icon
43
SLB Ltd
SLB
$75B
$4.28M 1.06%
50,060
+44,115
+742% +$4.06M
PEP icon
44
PepsiCo
PEP
$190B
$4.14M 1.03%
43,803
-954
-2% -$91.5K
OKS
45
DELISTED
Oneok Partners LP
OKS
$4M 0.99%
100,926
+2,740
+3% +$130K
AMJ
46
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$3.99M 0.99%
86,813
-90
-0.1% -$4.4K
CB
47
DELISTED
CHUBB CORPORATION
CB
$3.7M 0.92%
35,754
-405
-1% -$40.3K
MRO
48
DELISTED
Marathon Oil Corporation
MRO
$3.7M 0.92%
130,703
+14,905
+13% +$474K
CVX icon
49
Chevron
CVX
$366B
$3.66M 0.91%
32,620
+6,520
+25% +$741K
HES
50
DELISTED
Hess
HES
$3.31M 0.82%
44,836
+7,125
+19% +$564K

Similar funds

Novare Capital Management's Q4 2014 Portfolio in Review

As of Q4 2014, Novare Capital Management held 127 positions worth $402M, down 1.6% from $409M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Novare Capital Management's Q4 2014 filing shows 5 new, 49 increased, 44 reduced and 12 closed positions. Its largest new stake was Norfolk Southern: 45,305 shares worth $4.97M. The largest sale was Weatherford International plc, an estimated $5.31M.

By sector, the portfolio is most concentrated in Energy at 24% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Novare Capital Management's largest Q4 2014 buy was Norfolk Southern: 45,305 shares worth $4.97M.
  • Novare Capital Management added most to Pfizer in Q4 2014, an estimated $5.04M increase.
  • Novare Capital Management's biggest Q4 2014 reduction was IBM, cutting an estimated $3.05M.
  • Novare Capital Management fully exited Weatherford International plc in Q4 2014, selling an estimated $5.31M.
  • Novare Capital Management's ten largest holdings make up 25% of its $402M portfolio in Q4 2014.
  • Novare Capital Management opened 5 new positions and closed 12 in Q4 2014.
  • Novare Capital Management's portfolio value fell 1.6% quarter-over-quarter to $402M.

Based on Novare Capital Management's 13F filing for Q4 2014, filed 9 Feb 2015.